Stock Name: RafflesMG
Company Name: RAFFLES MEDICAL GROUP LTD
CIMB in June 10 research report says: "The Ministry of Health's new focus is not on lowering costs, but reviewing current funding frameworks and addressing capacity problems.
"Raffles Hospital's total bill size is already comparable to the average bill size for private hospitals, and is 4.1% ahead of the average for public hospitals. RFMD's management has already hinted at a gradual increase in medical charges this year across the board, which should provide stock catalysts for the group, in our opinion.
"Our earnings estimates and target price of $2.64 are intact, set at 23x CY12 P/E, its mid-cycle valuation. We expect other stock catalysts from the addition of clinics, expansion of medical specialties, and higher intensity cases in its hospital segment. MAINTAIN OUTPERFORM."
Company Name: RAFFLES MEDICAL GROUP LTD
| Research House: CIMB | Price Call: BUY | Target Price: 2.64 |
CIMB in June 10 research report says: "The Ministry of Health's new focus is not on lowering costs, but reviewing current funding frameworks and addressing capacity problems.
"Raffles Hospital's total bill size is already comparable to the average bill size for private hospitals, and is 4.1% ahead of the average for public hospitals. RFMD's management has already hinted at a gradual increase in medical charges this year across the board, which should provide stock catalysts for the group, in our opinion.
"Our earnings estimates and target price of $2.64 are intact, set at 23x CY12 P/E, its mid-cycle valuation. We expect other stock catalysts from the addition of clinics, expansion of medical specialties, and higher intensity cases in its hospital segment. MAINTAIN OUTPERFORM."
No comments:
Post a Comment